Why is DCTH Down Today?
About Delcath Systems Inc
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to admini...
Overall Confidence: 65%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector: -1.2%
Market Comparison
🔔 Get DCTH Alerts
We'll notify you when DCTH's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
DCTH has moved more than 3.0% down on 33 occasions in the past year.
Frequently Asked Questions
Why is DCTH stock down today?
This appears to be a sector-wide move. The SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector is down 1.2% on average.
Is DCTH stock a buy or sell right now?
Based on current analysis, DCTH shows 65% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the DCTH stock price target?
DCTH is currently trading at $15.42. Based on today's momentum, the expected short-term range is $14.95 - $15.72. See long-term price prediction →
Will DCTH stock continue falling?
Our analysis shows a 45% probability that DCTH's move continues in the next 1-3 days. Key level to watch: $14.64 (support).
Is DCTH stock oversold or overbought?
DCTH's RSI (Relative Strength Index) is currently at 42.3. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for DCTH stock?
DCTH's 10-day momentum indicator is at -0.84. Negative momentum - the stock has mild downward pressure which may continue short-term.
Is DCTH outperforming or underperforming the market?
DCTH (-3.48%) is currently significantly underperforming the market (-3.7% vs SPY). Today, the S&P 500 (SPY) is up 0.18%, and Nasdaq (QQQ) is up 0.31%.
What does MACD indicate for DCTH?
DCTH's MACD (-0.03) is currently below the signal line (0.09), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 15.9) is weak.
Is DCTH in an uptrend or downtrend?
Based on moving average analysis, DCTH is in a mixed/transitional trend. The price and moving averages are not clearly aligned, suggesting a potential trend change or consolidation phase. 20-day SMA: $16.06, 50-day SMA: $15.54.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis